Evidence for efflux pumps, other than PmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae N.P. Brenwald, P. Appelbaum, T. Davies,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.

R. Dumke, H. von Baum, P.C. Lück, E. Jacobs

In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria Matthew W. Ruble, Deborah H. Gilbert, Stephen.

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain A. Rivera, M. Rebollo, F. Sánchez, F. Navarro,

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

Herpes zoster in non-hospitalized children

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties J. Maugein, D. Guillemot, M.J. Dupont, T. Fosse,

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Evidence for efflux pumps, other than PmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae N.P. Brenwald, P. Appelbaum, T. Davies,

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Structure of grepafloxacin relative to activity and safety profile

D.E. Low Clinical Microbiology and Infection

Vector control: a cornerstone in the malaria elimination campaign

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Training for the infectious diseases speciality in Norway

The antibacterial effects of ciprofloxacin and trovafloxacin against Streptococcus pneumoniae in an in vitro dynamic model Matthew O'Brien, Thuy Quach,

Cephalosporins: a pharmacological update

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

D. Esel, B. Sümerkan, S. Kocagöz Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Viruses causing gastroenteritis

Levofloxacin in the treatment of ventilator-associated pneumonia

Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens* M. Kanellopoulou, A. Makri,

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

G.R. Davies Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

Pathogenesis of catheter-related infections: lessons for new designs

T.M. File Clinical Microbiology and Infection

Single- and multistep selection study of the antipneumococcal activity of BMS compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin

Community-acquired pneumonia: epidemiologic and clinical consideration

Training in infectious diseases and tropical medicine in Britain

A.P. Underwood, J. Green Clinical Microbiology and Infection

Fibronectin concentrations in catheter sepsis

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Clinical infection services—the Leiden experience

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Clinical Microbiology and Infection

W. Eugene Sanders, Christine C. Sanders

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

Antibiotic resistance of Helicobacter pylori: a cross-sectional study in consecutive patients, and relation to ethnicity R.J.L.F. Loffeld, C.A.P.M.J.

O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Typing of Clostridium difficile

New patterns of HIV-1 resistance during HAART

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

The future of diagnostic bacteriology

Presentation transcript:

Evidence for efflux pumps, other than PmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae N.P. Brenwald, P. Appelbaum, T. Davies, M.J. Gill Clinical Microbiology and Infection Volume 9, Issue 2, Pages 140-143 (February 2003) DOI: 10.1046/j.1469-0691.2003.00482.x Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Accumulation of ethidium bromide by Streptococcus pneumoniae strain R6:cat (parent; squares) and R6:cat-2 (mutant; triangles). Each point is the mean of three individual experiments; error bars represent — standard deviation. Fluorescent emission at 600nm is proportional to accumulation of ethidium bromide. Clinical Microbiology and Infection 2003 9, 140-143DOI: (10.1046/j.1469-0691.2003.00482.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions